BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37822938)

  • 1. Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes.
    Herzig MC; Christy BA; Montgomery RK; Cantu-Garza C; Barrera GD; Lee JH; Mucha N; Talackine JR; Abaasah IA; Bynum JA; Cap AP
    Front Immunol; 2023; 14():1225047. PubMed ID: 37822938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of human mesenchymal stromal cells with peripheral blood mononuclear cells in a Mitogenic proliferation assay.
    Herzig MC; Christy BA; Montgomery RK; Delavan CP; Jensen KJ; Lovelace SE; Cantu C; Salgado CL; Cap AP; Bynum JA
    J Immunol Methods; 2021 May; 492():113000. PubMed ID: 33609532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
    Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
    J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use.
    Torrents S; Del Moral AE; Codinach M; Rodríguez L; Querol S; Vives J
    Immunol Res; 2023 Oct; 71(5):725-734. PubMed ID: 37120479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire.
    Davies LC; Queckbörner S; Jylhä CE; Andrén AT; Forshell TZP; Blanc KL
    Cytotherapy; 2023 Sep; 25(9):956-966. PubMed ID: 37354149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta-derived multipotent mesenchymal stromal cells: a promising potential cell-based therapy for canine inflammatory brain disease.
    Amorim RM; Clark KC; Walker NJ; Kumar P; Herout K; Borjesson DL; Wang A
    Stem Cell Res Ther; 2020 Jul; 11(1):304. PubMed ID: 32698861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
    Bloom DD; Centanni JM; Bhatia N; Emler CA; Drier D; Leverson GE; McKenna DH; Gee AP; Lindblad R; Hei DJ; Hematti P
    Cytotherapy; 2015 Feb; 17(2):140-51. PubMed ID: 25455739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.
    Conforti A; Scarsella M; Starc N; Giorda E; Biagini S; Proia A; Carsetti R; Locatelli F; Bernardo ME
    Stem Cells Dev; 2014 Nov; 23(21):2591-9. PubMed ID: 24937591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.
    Paterson YZ; Rash N; Garvican ER; Paillot R; Guest DJ
    Stem Cell Res Ther; 2014 Jul; 5(4):90. PubMed ID: 25080326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro.
    Mckinnirey F; Herbert B; Vesey G; McCracken S
    Sci Rep; 2021 Jun; 11(1):12454. PubMed ID: 34127731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.
    Chinnadurai R; Copland IB; Garcia MA; Petersen CT; Lewis CN; Waller EK; Kirk AD; Galipeau J
    Stem Cells; 2016 Sep; 34(9):2429-42. PubMed ID: 27299362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
    Zimmermann JA; Hettiaratchi MH; McDevitt TC
    Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Human Bone Marrow Mesenchymal Stem Cells with Ectopic High OCT4 Expression on T Lymphocyte Function].
    Guo XP; Chen YF; Chen P; Pan J; Ying PT; Zhao N; Tang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1523-1530. PubMed ID: 37846711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Umbilical cord-mesenchymal stem cells induce a memory phenotype in CD4
    Sengun E; Wolfs TGAM; van Bruggen VLE; van Cranenbroek B; Simonetti ER; Ophelders D; de Jonge MI; Joosten I; van der Molen RG
    Front Immunol; 2023; 14():1128359. PubMed ID: 37409122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis.
    Zhang Z; Ding Y; Li W; Song B; Yang R
    Arthritis Res Ther; 2013 Oct; 15(5):R169. PubMed ID: 24286220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory Properties of Bone Marrow Mesenchymal Stem Cells from Patients with Amyotrophic Lateral Sclerosis and Healthy Donors.
    Javorkova E; Matejckova N; Zajicova A; Hermankova B; Hajkova M; Bohacova P; Kossl J; Krulova M; Holan V
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):215-225. PubMed ID: 30242613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem/stromal cell quality control: validation of mixed lymphocyte reaction assay using flow cytometry according to ICH Q2(R1).
    Nicotra T; Desnos A; Halimi J; Antonot H; Reppel L; Belmas T; Freton A; Stranieri F; Mebarki M; Larghero J; Cras A; Faivre L
    Stem Cell Res Ther; 2020 Oct; 11(1):426. PubMed ID: 33004063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing an immunomodulatory potency assay for Mesenchymal Stromal Cell.
    Hansen SB; Højgaard LD; Kastrup J; Ekblond A; Follin B; Juhl M
    Front Immunol; 2022; 13():1085312. PubMed ID: 36578497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.